bromocriptine has been researched along with gastrins in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (37.50) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barbier, P; de Graef, J; Reding, P | 1 |
Child, DF; Ganguli, PC; Laing, I | 1 |
Baba, M; Iishi, H; Okuda, S; Taniguchi, H; Tatsuta, M | 1 |
Bassetti, M; Beck-Peccoz, P; Bianchi, P; Faglia, G; Persani, L; Quatrini, M; Travella, B | 1 |
Baba, M; Ichii, M; Iishi, H; Nakaizumi, A; Taniguchi, H; Tatsuta, M; Uehara, H | 1 |
de Herder, WW; Hofland, LJ; Lamberts, SW; Uitterlinden, P; van Koetsveld, PM; Waaijers, M; Zuijderwijk, J | 1 |
Garg, SK; Michels, AW; Shah, VN | 1 |
1 review(s) available for bromocriptine and gastrins
Article | Year |
---|---|
Use of non-insulin therapies for type 1 diabetes.
Topics: Allylamine; Animals; Blood Glucose; Bromocriptine; Cardiovascular Diseases; Colesevelam Hydrochloride; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Dipeptidyl-Peptidase IV Inhibitors; Gastrins; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Islet Amyloid Polypeptide; Leptin; Metformin; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones; United States | 2013 |
7 other study(ies) available for bromocriptine and gastrins
Article | Year |
---|---|
Bromocriptine, gastric acid output, and gastrin secretion.
Topics: Administration, Oral; Adult; Animals; Bromocriptine; Cats; Ergolines; Female; Gastric Juice; Gastrins; Humans; Male; Middle Aged; Pentagastrin; Placebos; Stimulation, Chemical | 1977 |
Bromocriptine and gastrin secretion.
Topics: Administration, Oral; Adult; Aged; Bromocriptine; Gastrins; Humans; Middle Aged | 1978 |
Failure of oral bromocriptine to affect hypergastrinemia in two patients with the Zollinger-Ellison syndrome.
Topics: Adenoma; Adenoma, Islet Cell; Adult; Bromocriptine; Gastrins; Growth Hormone; Humans; Male; Middle Aged; Pancreatic Neoplasms; Peptic Ulcer; Zollinger-Ellison Syndrome | 1978 |
Enhancement of dopaminergic agonist bromocriptine of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats.
Topics: Adenocarcinoma; Animals; Bromocriptine; Dopamine; Epinephrine; Gastric Mucosa; Gastrins; Hydrogen-Ion Concentration; Male; Methylnitronitrosoguanidine; Neoplasms, Experimental; Norepinephrine; Rats; Rats, Inbred Strains; Stomach Neoplasms | 1992 |
Patterns of gastrin secretion in patients with nonfunctioning pituitary adenomas.
Topics: Adenoma; Adult; Aged; Analysis of Variance; Biomarkers, Tumor; Bromocriptine; Corticotropin-Releasing Hormone; Female; Gastrins; Gonadotropin-Releasing Hormone; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; Octreotide; Pentagastrin; Pituitary Gland; Pituitary Neoplasms; Secretin; Thyrotropin-Releasing Hormone | 1991 |
Attenuating effect of bromocriptine on cysteamine anticarcinogenesis of stomach cancers induced by N-methyl-N'-nitro-N-nitrosoguanidine.
Topics: Animals; Bromocriptine; Cysteamine; Drug Interactions; Gastric Acid; Gastric Mucosa; Gastrins; Male; Methylnitronitrosoguanidine; Mitotic Index; Norepinephrine; Rats; Rats, Inbred Strains; Reference Values; Stomach Neoplasms | 1990 |
Interferon-alpha-2a is a potent inhibitor of hormone secretion by cultured human pituitary adenomas.
Topics: Adenoma; Bromocriptine; Dopamine Agonists; Gastrinoma; Gastrins; Human Growth Hormone; Humans; Insulin; Insulin Secretion; Insulinoma; Interferon alpha-2; Interferon-alpha; Octreotide; Pancreatic Neoplasms; Pituitary Neoplasms; Prolactin; Prolactinoma; Recombinant Proteins; Somatostatin; Tumor Cells, Cultured | 1999 |